De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock (Q24235566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Reinaldo Salomao

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Brenda Nazaré Gomes Silva

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alvaro N Atallah

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

8 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

CD007934

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154391%20AND%20SRC:MED&resulttype=core&format=json

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Antibiotic usage in an intensive care unit in a Danish university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin leve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Procalcitonin in liver transplant patients--yet another stone turned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Blood culture isolates in hemodialysis vascular catheter-related bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Sepsis and septic shock: selection of empiric antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Prescription of antibiotic agents in Swedish intensive care units is empiric and precise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Impact of increasing antimicrobial resistance on wound management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

An update on the synthesis and antibacterial effects of carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Antibiotic regimens for suspected late onset sepsis in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Streamlining antimicrobial therapy for lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

[Epidemiology and costs of severe sepsis in Madrid. A hospital discharge study].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Hospital-acquired pneumonia and de-escalation of antimicrobial treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

How to break the vicious circle of antibiotic resistances?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Monitoring the treatment of sepsis with vancomycin in term newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Severe pseudomonal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Severe soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

De-escalation therapy in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

De-escalation therapy in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Two decades of imipenem therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Brazilian Sepsis Epidemiological Study (BASES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Sepsis in European intensive care units: results of the SOAP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

[Sepsis management -- antibiotic therapy]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care VII--Guidelines for antibiotic administration in severely injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Meta-analysis of procalcitonin for sepsis detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Diagnose und kausale Therapie der Sepsis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Clinical impact of an infectious disease service on the management of bloodstream infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Current perspectives on antibiotic use in the treatment of surgical infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

[Investigation methods in clinical cardiology. IV. Clinical measurements in cardiology: validity and errors of measurements]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Indications for antibiotic use in ICU patients: a one-year prospective surveillance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Definitions for sepsis and organ failure.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Utilization and diagnostic yield of blood cultures in a surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Low-dose vasopressin in the treatment of vasodilatory septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Procalcitonin increase in early identification of critically ill patients at high risk of mortality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021

Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007934.PUB2

7 January 2021